# US 2026/0166207 A1 · Method for operating a device for extracorporeal blood treatment, and device for extracorporeal blood treatment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0166207 A1
- Document ID: US20260166207A1
- Status: Published application
- Kind: A1
- Application number: 19/421,658
- Filed: 2025-12-16
- Published: 2026-06-18
- Earliest claimed: 2024-12-17
- Applicants: B. Braun Avitum AG
- Inventors: Heiko Riemenschneider; Reinhardt Peters
- Web page: https://patentgrep.com/patent/US20260166207A1

## CPC

- A61M 1/1603: {Regulation parameters}
- A61M 1/3437: {downstream of the filter, e.g. post-dilution with filtrate}
- A61M 1/3403: {Regulation parameters}
- A61M 1/3413: {Diafiltration}
- A61M 1/3434: {with pre-dilution and post-dilution}
- A61M 1/3441: {Substitution rate control as a function of the ultrafiltration rate}
- A61M 1/3465: {using dialysate as substitution fluid}
- A61M 2202/0021: removed from and reintroduced into the body, e.g. after treatment
- A61M 2202/0413: Blood
- A61M 2205/10: with powered movement mechanisms
- A61M 2205/3317: Electromagnetic, inductive or dielectric measuring means
- A61M 2205/3331: Pressure; Flow
- A61M 2205/3379: Masses, volumes, levels of fluids in reservoirs, flow rates
- A61M 2205/50: with microprocessors or computers
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A method is used to operate a device for extracorporeal blood treatment. The device can perform haemodialysis and hemodiafiltration. During hemodiafiltration, blood is delivered through a blood side of a dialyzer by an electric blood pump. Substituate is delivered by an electric substituate pump. A delivery volumetric flow of the electric substituate pump is adjusted in such a way that a current consumption of the electric blood pump remains within predefinable limit values.

## Claims

### Claim 1

A method for operating a device for extracorporeal blood treatment, the device configured to perform hemodiafiltration and haemodialysis, the method comprising the steps of:
delivering blood through a blood side of a dialyzer with an electric blood pump during hemodiafiltration;
delivering substituate via an electric substituate pump; and
adjusting a delivery volumetric flow of the electric substituate pump in such a way that a current consumption of the electric blood pump remains within predefinable limit values, the predefinable limit values comprising an upper limit value and a lower limit value.

### Claim 2 (depends on 1)

The method according to claim 1, wherein:
when the current consumption of the electric blood pump rises above the upper limit value, the delivery volumetric flow of the electric substituate pump is reduced, and,
when the current consumption of the electric blood pump drops below the lower limit value, the delivery volumetric flow of the electric substituate pump is increased.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the substituate is fed to a blood circulation of a patient by post-dilution.

### Claim 4 (depends on 1)

The method according to claim 1, further comprising the steps of:
performing haemodialysis with the device;
monitoring the dialyzer continuously to ascertain whether a secondary membrane has formed on a membrane of the dialyzer; and
switching to hemodiafiltration as soon as the secondary membrane has formed on the membrane of the dialyzer.

### Claim 5 (depends on 4)

The method according to claim 4, further comprising the steps of:
setting a predefined cross rate after switching to hemodiafiltration;
measuring a current consumption of the electric blood pump at the predefined cross rate; and
calculating the predefinable limit values according to said current consumption.

### Claim 6 (depends on 5)

The method according to claim 5, wherein
the upper limit value is predefined in a range between 115% and 135% of said current consumption, and/or
the lower limit value is predefined as 0.8 times to 0.95 times the upper limit value.

### Claim 7 (depends on 1)

A device for extracorporeal blood treatment for performing the method according to claim 1, the device comprising:
a dialyzer;
an electric blood pump for delivering blood through a blood side of the dialyzer;
an electric substituate pump for delivering substituate; and
a controller that controls the electric blood pump and the electric substituate pump.
